Literature DB >> 12899412

Immunostimulatory CpG oligodeoxynucleotides increase resistance against amoebic gill disease in Atlantic salmon, Salmo salar L.

A R Bridle1, R Butler, B F Nowak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12899412     DOI： 10.1046/j.1365-2761.2003.00457.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN： 0140-7775            Impact factor:   2.767


× No keyword cloud information.
  3 in total

1.  The viscosity and glycoprotein biochemistry of salmonid mucus varies with species, salinity and the presence of amoebic gill disease.

Authors:  Shane D Roberts; Mark D Powell
Journal:  J Comp Physiol B       Date:  2004-10-29       Impact factor: 2.200

2.  Transcriptome analyses of amoebic gill disease-affected Atlantic salmon (Salmo salar) tissues reveal localized host gene suppression.

Authors:  James W Wynne; Maree G O'Sullivan; Mathew T Cook; Glenn Stone; Barbara F Nowak; David R Lovell; Nicholas G Elliott
Journal:  Mar Biotechnol (NY)       Date:  2008-01-25       Impact factor: 3.619

Review 3.  Experimental Challenge Models and In Vitro Models to Investigate Efficacy of Treatments and Vaccines against Amoebic Gill Disease.

Authors:  Jemma Hudson; Barbara F Nowak
Journal:  Microorganisms       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.